Penumbra Inc logo

Penumbra Inc

2
NYSE:PEN (USA)  
$ 176.03 -11.29 (-6.03%) 12:09 AM EST
74.27
P/B:
5.67
Volume:
469.41K
Avg Vol (2M):
337.21K
Trade In:
Volume:
469.41K
Avg Vol (2M):
337.21K

Business Description

Description
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 1.35
Equity-to-Asset 0.76
Debt-to-Equity 0.19
Debt-to-EBITDA 2.04
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 8/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 13.17
Distress
Grey
Safe
Beneish M-Score -2.52
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 14.57
9-Day RSI 23.85
14-Day RSI 29.26
6-1 Month Momentum % -17.73
12-1 Month Momentum % -39.67

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.12
Quick Ratio 3.51
Cash Ratio 2.05
Days Inventory 355.11
Days Sales Outstanding 67.73
Days Payable 26.99

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2
Shareholder Yield % -0.07

Financials (Next Earnings Date:2024-08-01 Est.)

PEN's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NYSE:PEN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Penumbra Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1,095.779
EPS (TTM) ($) 2.37
Beta 1.01
Volatility % 40.36
14-Day RSI 29.26
14-Day ATR ($) 6.544397
20-Day SMA ($) 190.5815
12-1 Month Momentum % -39.67
52-Week Range ($) 175.03 - 348.67
Shares Outstanding (Mil) 38.76

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Penumbra Inc Filings

Filing Date Document Date Form
No Filing Data

Penumbra Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Penumbra Inc Frequently Asked Questions

What is Penumbra Inc(PEN)'s stock price today?
The current price of PEN is $176.03. The 52 week high of PEN is $348.67 and 52 week low is $175.03.
When is next earnings date of Penumbra Inc(PEN)?
The next earnings date of Penumbra Inc(PEN) is 2024-08-01 Est..
Does Penumbra Inc(PEN) pay dividends? If so, how much?
Penumbra Inc(PEN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1